References
- Arnáiz B, Martínez-Ávila O, Falcon-Perez JM, et al. (2012). Cellular uptake of gold nanoparticles bearing HIV gp120 oligomannosides. Bioconjug Chem 23:814–25.
- Aykaç A, Martos-Maldonado MC, Casas-Solvas JM, et al. (2014). β-Cyclodextrin-bearing gold glyconanoparticles for the development of site specific drug delivery systems. Langmuir 30:234–42.
- Besford QA, Wojnilowicz M, Suma T, et al. (2017). Lactosylated glycogen nanoparticles for targeting prostate cancer cells. ACS Appl Mater Interfaces 9:16869–79.
- Calderon-Gonzalez R, Terán-Navarro H, García I, et al. (2017). Gold glyconanoparticles coupled to listeriolysin O 91-99 peptide serve as adjuvant therapy against melanoma. Nanoscale 9:10721–32.
- Carvalho d. S A, Vliegenthart JF, Kamerling JP. (2008). Gold nanoparticles coated with a pyruvated trisaccharide epitope of the extracellular proteoglycan of Microciona prolifera as potential tools to explore carbohydrate-mediated cell recognition. Org Biomol Chem 6:2095–102.
- Chiodo F, Marradi M, Calvo J, et al. (2014). Glycosystems in nanotechnology: gold glyconanoparticles as carrier for anti-HIV prodrugs. Beilstein J Org Chem 10:1339–46.
- Chiodo F, Marradi M. (2015). Gold nanoparticles as carriers for synthetic glycoconjugate vaccines. In Carbohydrate-based vaccines, Lepenies B (Ed.). New York: Springer, 159.
- Conde J, Tian F, Hernandez Y, et al. (2015). RNAi-based glyconanoparticles trigger apoptotic pathways for in vitro and in vivo enhanced cancer-cell killing. Nanoscale 7:9083–91.
- de la Fuente JM, Alcántara D, Eaton P, et al. (2006). Gold and gold-iron oxide magnetic glyconanoparticles: synthesis, characterization and magnetic properties. J Phys Chem B 110:13021–8.
- de la Fuente JM, Barrientos AG, Rojas TC, et al. (2001). Gold glyconanoparticles as water-soluble polyvalent models to study carbohydrate interactions. Angew Chem Int Ed 40:2257–61.
- El-Boubbou K, Gruden C, Huang X. (2007). Magnetic glyco-nanoparticles: a unique tool for rapid pathogen detection, decontamination, and strain differentiation. J Am Chem Soc 129:13392–3.
- Farr TD, Lai CH, Grünstein D, et al. (2014). Imaging early endothelial inflammation following stroke by core shell silica superparamagnetic glyconanoparticles that target selectin. Nano Lett 14:2130–4.
- Fasman EGD, Gerald D. (1975). Handbook of biochemistry and molecular biology: lipids, carbohydrated, steroids. Florida, USA: CRC Press.
- Gallegos-Tabanico A, Sarabia-Sainz JA, Sarabia-Sainz HM, et al. (2017). Molecular recognition of glyconanoparticles by RCA and E. coli K88-designing transports for targeted therapy. Acta Biochim Pol 64:671–7.
- Gallo J, García I, Genicio N, et al. (2011). Specific labelling of cell populations in blood with targeted immuno-fluorescent/magnetic glyconanoparticles. Biomaterials 32:9818–25.
- García I, Gallo J, Genicio N, et al. (2011). Magnetic glyconanoparticles as a versatile platform for selective immunolabeling and imaging of cells. Bioconjug Chem 22:264–73.
- García I, Marradi M, Penadés S. (2010). Glyconanoparticles: multifunctional nanomaterials for biomedical applications. Nanomedicine (Lond) 5:777–92.
- Grillon C, Matejuk A, Nadim M. (2012). News on microenvironmental physioxia to revisit skin cell targeting approaches. Exp Dermatol 21:723–8.
- Hakomori S. (2001). Tumor-associated carbohydrate antigens defining tumor malignancy: basis for development of anti-cancer vaccines. Adv Exp Med Biol 491:369–402.
- Han E, Ding L, Ju H. (2011). Highly sensitive fluorescent analysis of dynamic glycan expression on living cells using glyconanoparticles and functionalized quantum dots. Anal Chem 83:7006–12.
- Jafari MS, Khoshchehreh R, Goodarzi N, et al. (2014). cis-Dichlorodiamminoplatinum (II) glyconanoparticles by drug-induced ionic gelation technique targeted to prostate cancer: preparation, optimization and in vitro characterization. Colloids Surf B Biointerfaces 122:350–8.
- Jiang X, Ahmed M, Deng Z, et al. (2009). Biotinylated glyco-functionalized quantum dots: synthesis, characterization, and cytotoxicity studies. Bioconjug Chem 20:994–1001.
- Kasteren SIV, Campbell SJ, Serres S, et al. (2009). Glyconanoparticles allow pre-symptomatic in vivo imaging of brain disease. Proc Natl Acad Sci U S A 106:18–23.
- Kekkonen V, Lafreniere N, Ebara M, et al. (2009). Synthesis and characterization of biocompatible magnetic glyconanoparticles. J Magn Magn Mater 321:1393–6.
- Kikkeri RV, Bavireddi H. (2012). Glyco-[small beta]-cyclodextrin capped quantum dots: synthesis, cytotoxicity and optical detection of carbohydrate–protein interactions. Analyst 137:5123–7.
- Kulkarni AA, Fuller C, Korman H, et al. (2010). Glycan encapsulated gold nanoparticles selectively inhibit shiga toxins 1 and 2. Bioconjug Chem 21:1486–93.
- Liu S, Shi F, Zhao X, et al. (2013). 3-Aminophenyl boronic acid-functionalized CuInS2 quantum dots as a near-infrared fluorescence probe for the determination of dopamine. Biosens Bioelectron 47:379–84.
- Marradi M, Martín-Lomas M, Penadés S. (2010). Glyconanoparticles polyvalent tools to study carbohydrate-based interactions. Adv Carbohydr Chem Biochem 64:211–90.
- Mirkin G. (1973). Carbohydrate loading: a dangerous practice. JAMA 223:1511–12.
- Nagahori N, Abe M, Nishimura SI. (2009). Structural and functional glycosphingolipidomics by glycoblotting with aminooxy-functionalized gold nanoparticle. Biochemistry 48:583–94.
- Nieman DC. (1998). Influence of carbohydrate on the immune response to intensive, prolonged exercise. Exerc Immunol Rev 4:64–76.
- Ojeda R, de Paz JL, Barrientos AG, et al. (2007). Preparation of multifunctional glyconanoparticles as a platform for potential carbohydrate-based anticancer vaccines. Carbohydr Res 342:448–59.
- Park S, Kim G-H, Park S-H, et al. (2015). Probing cell-surface carbohydrate binding proteins with dual-modal glycan-conjugated nanoparticles. J Am Chem Soc 137:5961–8.
- Qian R-C, Lv J, Li H-W, Long Y-T. (2017). Sugar-coated nanobullet: growth inhibition of cancer cells induced by metformin loaded glyconanoparticles. ChemMedChem 12:1823–7.
- Schofield CL, And RAF, Russell DA. (2007). Glyconanoparticles for the colorimetric detection of cholera toxin. Anal Chem 79:1356–61.
- Sundgren A, Barchi JJ Jr. (2008). Varied presentation of the Thomsen-Friedenreich disaccharide tumor-associated carbohydrate antigen on gold nanoparticles. Carbohydr Res 343:1594–604.
- Sundhoro M, Park J, Jayawardana KW, et al. (2017). Poly(HEMA-co-HEMA-PFPA): synthesis and preparation of stable micelles encapsulating imaging nanoparticles. J Colloid Interface Sci 500:1–8.
- Töpfer-Petersen E. (1999). Carbohydrate-based interactions on the route of a spermatozoon to fertilization. Hum Reprod Update 5:314–29.
- Wang X, Matei E, Deng L, et al. (2013). Sensing lectin–glycan interactions using lectin super-microarrays and glycans labeled with dye-doped silica nanoparticles. Biosens Bioelectron 47:258–64.
- Wang X, Ramstro¨m O, Yan M. (2010). Quantitative analysis of multivalent ligand presentation on gold glyconanoparticles and their effects on protein binding. Anal Chem 82:9082–9.
- Won S, Hindmarsh S, Gibson MI. (2018). Triggerable multivalent glyconanoparticles for probing carbohydrate-carbohydrate interactions. ACS Macro Lett 7:178–83.
- Wu L, Zhang Y, Li Z, et al. (2017). “Sweet” architecture-dependent uptake of glycocalyx-mimicking nanoparticles based on biodegradable aliphatic polyesters by macrophages. J Am Chem Soc 139:14684–92.
- Yang Y, Xue XC, Jin XF, et al. (2012). Synthesis of multivalent N-acetyl lactosamine modified quantum dots for the study of carbohydrate and galectin-3 interactions. Tetrahedron 68:7148–54.
- Yang Y, Yu M, Yan TT, et al. (2010). Characterization of multivalent lactose quantum dots and its application in carbohydrate-protein interactions study and cell imaging. Bioorg Med Chem 18:5234–40.
- Yang Y, Zhao YT, Yan TT, et al. (2010). Design and fabrication of multivalent gal-containing quantum dots and study of its interactions with asialoglycoprotein receptor (ASGP-R). Tetrahedron Lett 51:4182–5.
- Zhou J, Hao N, Zoyza TD, et al. (2015). Lectin-gated, mesoporous, photofunctionalized glyconanoparticles for glutathione-responsive drug delivery. Chem Commun 51:9833–6.